Cargando…

Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects

BACKGROUND: Tendon is a major component of musculoskeletal system connecting the muscles to the bone. Tendon injuries are very common orthopedics problems leading to impeded motion. Up to now, there still lacks effective treatments for tendon diseases. METHODS: Tendon stem/progenitor cells (TSPCs) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yonghui, Zhou, Bingyu, Ni, Ming, Wang, Min, Ding, Lingli, Li, Ying, Liu, Yamei, Zhang, Wencai, Li, Gang, Wang, Jiali, Xu, Liangliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744263/
https://www.ncbi.nlm.nih.gov/pubmed/35012661
http://dx.doi.org/10.1186/s13287-021-02679-x
_version_ 1784630081574928384
author Hou, Yonghui
Zhou, Bingyu
Ni, Ming
Wang, Min
Ding, Lingli
Li, Ying
Liu, Yamei
Zhang, Wencai
Li, Gang
Wang, Jiali
Xu, Liangliang
author_facet Hou, Yonghui
Zhou, Bingyu
Ni, Ming
Wang, Min
Ding, Lingli
Li, Ying
Liu, Yamei
Zhang, Wencai
Li, Gang
Wang, Jiali
Xu, Liangliang
author_sort Hou, Yonghui
collection PubMed
description BACKGROUND: Tendon is a major component of musculoskeletal system connecting the muscles to the bone. Tendon injuries are very common orthopedics problems leading to impeded motion. Up to now, there still lacks effective treatments for tendon diseases. METHODS: Tendon stem/progenitor cells (TSPCs) were isolated from the patellar tendons of SD rats. The expression levels of genes were evaluated by quantitative RT-PCR. Immunohistochemistry staining was performed to confirm the presence of tendon markers in tendon tissues. Bioinformatics analysis of data acquired by RNA-seq was used to find out the differentially expressed genes. Rat patellar tendon injury model was used to evaluate the effect of U0126 on tendon injury healing. Biomechanical testing was applied to evaluate the mechanical properties of newly formed tendon tissues. RESULTS: In this study, we have shown that ERK inhibitor U0126 rather PD98059 could effectively increase the expression of tendon-related genes and promote the tenogenesis of TSPCs in vitro. To explore the underlying mechanisms, RNA sequencing was performed to identify the molecular difference between U0126-treated and control TSPCs. The result showed that GDF6 was significantly increased by U0126, which is an important factor of the TGFβ superfamily regulating tendon development and tenogenesis. In addition, NBM (nonwoven-based gelatin/polycaprolactone membrane) which mimics the native microenvironment of the tendon tissue was used as an acellular scaffold to carry U0126. The results demonstrated that when NBM was used in combination with U0126, tendon healing was significantly promoted with better histological staining outcomes and mechanical properties. CONCLUSION: Taken together, we have found U0126 promoted tenogenesis in TSPCs through activating GDF6, and NBM loaded with U0126 significantly promoted tendon defect healing, which provides a new treatment for tendon injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02679-x.
format Online
Article
Text
id pubmed-8744263
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87442632022-01-11 Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects Hou, Yonghui Zhou, Bingyu Ni, Ming Wang, Min Ding, Lingli Li, Ying Liu, Yamei Zhang, Wencai Li, Gang Wang, Jiali Xu, Liangliang Stem Cell Res Ther Research BACKGROUND: Tendon is a major component of musculoskeletal system connecting the muscles to the bone. Tendon injuries are very common orthopedics problems leading to impeded motion. Up to now, there still lacks effective treatments for tendon diseases. METHODS: Tendon stem/progenitor cells (TSPCs) were isolated from the patellar tendons of SD rats. The expression levels of genes were evaluated by quantitative RT-PCR. Immunohistochemistry staining was performed to confirm the presence of tendon markers in tendon tissues. Bioinformatics analysis of data acquired by RNA-seq was used to find out the differentially expressed genes. Rat patellar tendon injury model was used to evaluate the effect of U0126 on tendon injury healing. Biomechanical testing was applied to evaluate the mechanical properties of newly formed tendon tissues. RESULTS: In this study, we have shown that ERK inhibitor U0126 rather PD98059 could effectively increase the expression of tendon-related genes and promote the tenogenesis of TSPCs in vitro. To explore the underlying mechanisms, RNA sequencing was performed to identify the molecular difference between U0126-treated and control TSPCs. The result showed that GDF6 was significantly increased by U0126, which is an important factor of the TGFβ superfamily regulating tendon development and tenogenesis. In addition, NBM (nonwoven-based gelatin/polycaprolactone membrane) which mimics the native microenvironment of the tendon tissue was used as an acellular scaffold to carry U0126. The results demonstrated that when NBM was used in combination with U0126, tendon healing was significantly promoted with better histological staining outcomes and mechanical properties. CONCLUSION: Taken together, we have found U0126 promoted tenogenesis in TSPCs through activating GDF6, and NBM loaded with U0126 significantly promoted tendon defect healing, which provides a new treatment for tendon injury. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02679-x. BioMed Central 2022-01-10 /pmc/articles/PMC8744263/ /pubmed/35012661 http://dx.doi.org/10.1186/s13287-021-02679-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hou, Yonghui
Zhou, Bingyu
Ni, Ming
Wang, Min
Ding, Lingli
Li, Ying
Liu, Yamei
Zhang, Wencai
Li, Gang
Wang, Jiali
Xu, Liangliang
Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects
title Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects
title_full Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects
title_fullStr Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects
title_full_unstemmed Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects
title_short Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects
title_sort nonwoven-based gelatin/polycaprolactone membrane loaded with erk inhibitor u0126 for treatment of tendon defects
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744263/
https://www.ncbi.nlm.nih.gov/pubmed/35012661
http://dx.doi.org/10.1186/s13287-021-02679-x
work_keys_str_mv AT houyonghui nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT zhoubingyu nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT niming nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT wangmin nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT dinglingli nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT liying nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT liuyamei nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT zhangwencai nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT ligang nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT wangjiali nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects
AT xuliangliang nonwovenbasedgelatinpolycaprolactonemembraneloadedwitherkinhibitoru0126fortreatmentoftendondefects